Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 4Breast 3Thoracic 2Sarcoma 2Tumor-Agnostic 1Plasma cell 1Other solid neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thymus Neoplasms 1Mesothelioma 1Carcinoma, Squamous Cell 1Adenocarcinoma 1

Interventions

Carboplatin 347pembrolizumab 322Pemetrexed 246Cisplatin 218Paclitaxel 147Nivolumab 138durvalumab 133osimertinib 112Docetaxel 111atezolizumab 109Specimen Handling 91Radiotherapy 87Drug Therapy 85Magnetic Resonance Spectroscopy 77Etoposide 76Radiosurgery 72Gemcitabine 71Ipilimumab 55130-nm albumin-bound paclitaxel 54Bevacizumab 52cemiplimab 47tislelizumab 44Blood Specimen Collection 40Cetuximab 35Taxes 34Platinum 33Injections 33Biopsy 33Standard of Care 31Immunoglobulin G 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Quality of Life × Thoracic × 1 year × Clear all
NCT06646471 2026-04-29

PROMETHEE

Groupe Francais De Pneumo-Cancerologie

Phase 4 Recruiting
500 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06996249 2026-03-03

DuTOC

Dutch Society of Physicians for Pulmonology and Tuberculosis

Recruiting
12,000 enrolled
Other solid neoplasmThoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Mesothelioma, Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡